The trajectory of Viagra presents a intricate picture for investors. While the initial introduction generated substantial gains, the expiration of its exclusive rights opened the avenue to generic alternatives, https://socialaffluent.com/story7270930/the-copyright-and-pharma-a-risky-opportunity